Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BAYGN | Derived | EUR | Real-time | |
BAYGn | Xetra | EUR | Delayed | |
BAYNd | BATS Europe | EUR | Delayed | |
BAYRY | OTC Markets | USD | Delayed | |
0P6S | London | EUR | Real-time | |
BAYNN | BIVA | MXN | Delayed | |
BAYNN | Mexico | MXN | Delayed | |
BAYG | Milan | EUR | Real-time | |
BAYGn | Dusseldorf | EUR | Delayed | |
BAYGn | Hamburg | EUR | Delayed | |
BAYGn | TradeGate | EUR | Delayed | |
BAYGn | Frankfurt | EUR | Delayed | |
BAY1 | Warsaw | PLN | Delayed | |
BAYGn | Vienna | EUR | Real-time | |
BAYG | Budapest | HUF | Delayed | |
BAYN | Bucharest | RON | Delayed |
For the six months ended 30 June 2020, Bayer AG revenues decreased less than 1% to EUR22.9B. Net loss before extraordinary items totaled EUR8.25B vs. income of EUR1.45B. Revenues reflect CropScience segment increase of 4% to EUR11.64B, Pharmaceuticals - Xarelto segment increase of 12% to EUR2.17B, North America segment increase of 1% to EUR9.18B, also reflect Consumer Care segment decrease of 8% to EUR2.6B.
Period Ending: | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 |
---|---|---|---|---|
Total Revenue | 10054 | 12845 | 10750 | 9830 |
Gross Profit | 6036 | 8189 | 5875 | 6087 |
Operating Income | -10784 | 2499 | 396 | 1215 |
Net Income | -9548 | 1489 | 1414 | 1036 |
Period Ending: | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 |
---|---|---|---|---|
Total Assets | 123667 | 125474 | 126174 | 130763 |
Total Liabilities | 87963 | 76865 | 78921 | 84798 |
Total Equity | 35704 | 48609 | 47253 | 45965 |
Period Ending: | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | 2178 | -236 | 8187 | 4960 |
Cash From Investing Activities | -1019 | -598 | -671 | -706 |
Cash From Financing Activities | -1090 | 36 | -8389 | -3918 |
Net Change in Cash | -30 | -866 | -867 | 358 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review